Table 1.
Body- and organ weight.
| Dose (mg/ml) | Bodyweight at experiment start (g) | Bodyweight at euthanization (g) | Liver (g) | Spleen (g) | Kidneys (g) | Brain (g) | Lungs (g) | Adrenal glands (g) | Heart (g) |
|---|---|---|---|---|---|---|---|---|---|
| 0 mg/ml (n=5) | 575±41 | 620±42 | 16.9±0.8 | 1.20±0.37 | 4.18±0.59 | 4.20±0.16 | 3.62±0.31 | 0.299±0.051 | 1.56±0.18 |
| Ascorbate 1 mg/ml (n=5) | 562±20 | 647±32 | 19.5±4.0 | 0.68±0.04** | 3.92±0.23 | 3.85±0.07 | 3.48±0.50 | 0.285±0.070 | 1.60±0.16 |
| Ascorbate 0.5 mg/ml (n=5) | 553±44 | 629±59 | 17.0±4.4 | 0.74±0.19** | 4.06±0.75 | 4.06±0.27 | 3.36±0.36 | 0.270±0.051 | 1.58±0.25 |
| Ascorbate 0.25 mg /ml (n=5) | 568±13 | 668±26 | 19.1±2.6 | 0.74±0.05* | 3.82±0.13 | 3.94±0.15 | 3.46±0.26 | 0.278±0.020 | 1.60±0.07 |
| Ascorbate 0.1 mg/ml (n=5) | 566±46 | 636±60 | 16.0±2.2 | 0.72±0.08** | 3.80±0.37 | 4.03±0.27 | 3.34±0.29 | 0.231±0.031 | 1.54±0.18 |
| DHA 1 mg/ml (n=5) | 574±32 | 674±49 | 19.1±2.8 | 0.86±0.15 | 4.02±0.30 | 4.02±0.11 | 3.52±0.31 | 0.256±0.035 | 1.64±0.13 |
| DHA 0.5 mg/ml (n=5) | 563±20 | 666±23 | 18.0±1.0 | 0.90±0.22 | 4.02±0.19 | 4.00±0.10 | 3.48±0.19 | 0.271±0.037 | 1.58±0.23 |
| DHA 0.25 mg/ml (n=5) |
553±25 |
663±31 |
18.9±0.5 |
0.80±0.10 |
4.16±0.21 |
3.91±0.10 |
3.52±0.08 |
0.256±0.047 |
1.64±0.17 |
Bodyweights from the beginning and end of the experiment are provided. The individual organ weights were assessed upon dissection. *=p≤0.05; **p≤0.01 as compared to “0 mg/ml” by one-way ANOVA using Bonferroni correction for multiple comparisons.